HK1142001A1 - Preparation for transnasal application - Google Patents
Preparation for transnasal applicationInfo
- Publication number
- HK1142001A1 HK1142001A1 HK10108585.2A HK10108585A HK1142001A1 HK 1142001 A1 HK1142001 A1 HK 1142001A1 HK 10108585 A HK10108585 A HK 10108585A HK 1142001 A1 HK1142001 A1 HK 1142001A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- transnasal application
- transnasal
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Inorganic Chemistry (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006350094 | 2006-12-26 | ||
PCT/JP2007/074787 WO2008078730A1 (ja) | 2006-12-26 | 2007-12-25 | 経鼻投与用製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1142001A1 true HK1142001A1 (en) | 2010-11-26 |
Family
ID=39562519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10108585.2A HK1142001A1 (en) | 2006-12-26 | 2010-09-10 | Preparation for transnasal application |
Country Status (7)
Country | Link |
---|---|
US (2) | US8337817B2 (ja) |
EP (1) | EP2116264B1 (ja) |
JP (2) | JP5415769B2 (ja) |
CN (1) | CN101668544B (ja) |
ES (1) | ES2652415T3 (ja) |
HK (1) | HK1142001A1 (ja) |
WO (1) | WO2008078730A1 (ja) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2224792B1 (es) * | 2002-06-28 | 2007-02-16 | Era Plantech, S.L. | Produccion de peptidos y proteinas por acumulacion de cuerpos proteicos derivados de reticulos endoplasmico en plantas. |
US7638138B2 (en) | 2003-02-21 | 2009-12-29 | Translational Research, Ltd. | Compositions for nasal administration of pharmaceuticals |
AU2003220808B2 (en) | 2003-03-27 | 2008-08-21 | Bioactis Limited | Powder medicine applicator for nasal cavity |
JP4922762B2 (ja) * | 2004-08-10 | 2012-04-25 | 株式会社新日本科学 | 速効性でかつ高い吸収性を可能とする経鼻投与用組成物 |
ES2652415T3 (es) | 2006-12-26 | 2018-02-02 | Shin Nippon Biomedical Laboratories, Ltd. | Preparación para aplicación transnasal |
US9132195B2 (en) * | 2008-05-21 | 2015-09-15 | Asahi Kasei Chemicals Corporation | Cellulose powder having excellent segregation preventive effect, and compositions thereof |
ES2419204T3 (es) * | 2008-05-27 | 2013-08-19 | The University Of Melbourne | Métodos para tratar a mamíferos con disfunciones de la trompa de Eustaquio |
KR20110084906A (ko) | 2008-10-10 | 2011-07-26 | 에라 바이오테크, 에스.에이. | 면역원-특이적 면역보강제로서의 재조합 단백질체들 |
US20120040970A1 (en) * | 2009-04-27 | 2012-02-16 | Al-Ghananeem Abeer M | Intranasal delivery system for dantrolene |
JP2012526726A (ja) * | 2009-05-15 | 2012-11-01 | 株式会社新日本科学 | 薬物動態が改善された鼻腔内用薬学的組成物 |
WO2011013003A2 (en) * | 2009-07-31 | 2011-02-03 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
RU2012144612A (ru) | 2010-04-15 | 2014-05-20 | Син Ниппон Байомедикал Лэборэтэриз, Лтд. | Способ и композиции для интраназальной доставки |
MX343509B (es) * | 2011-04-06 | 2016-11-08 | Dow Global Technologies Llc | Proceso para producir derivados de celulosa de alta densidad aparente y buena fluidez. |
US20150018379A1 (en) | 2011-05-13 | 2015-01-15 | Euro-Celtique S.A. | Intranasal Pharmaceutical Dosage Forms Comprising Naloxone |
WO2013059213A1 (en) | 2011-10-18 | 2013-04-25 | Amidebio, Llc | Chemically and thermodynamically stable insulin analogues and improved methods for their production |
ES2634993T3 (es) | 2012-03-30 | 2017-10-02 | Nuformix Limited | Composiciones y cocristales de tranilast |
US9789071B2 (en) | 2012-06-27 | 2017-10-17 | G2B Pharma, Inc. | Intranasal formulation of epinephrine for the treatment of anaphylaxis |
MX2015011624A (es) | 2013-03-04 | 2015-12-17 | Besins Healthcare Lu Sarl | Composiciones farmaceuticas secas que comprenden nanoparticulas de agente activo ligadas a particulas portadoras. |
US11554229B2 (en) | 2013-03-26 | 2023-01-17 | OptiNose Inc. | Nasal administration |
SG11201507981TA (en) * | 2013-03-26 | 2015-10-29 | Optinose As | Nasal administration |
WO2014172488A2 (en) | 2013-04-17 | 2014-10-23 | AmideBio LLC | Chemically and thermodynamically stable insulin analogues and improved methods for their production |
AU2014315459A1 (en) * | 2013-09-03 | 2016-04-07 | G2B Pharma Inc. | Intranasal formulation for the treatment of cardiopulmonary resuscitation (CPR), cardiac life support (CLS), anaphylaxis and/or anaphylactoid reactions |
ES2904570T3 (es) * | 2013-09-24 | 2022-04-05 | Satsuma Pharmaceuticals Inc | Formulación de DHE intranasal para el tratamiento del dolor de cabeza |
US9192570B2 (en) | 2013-12-20 | 2015-11-24 | AntiOP, Inc. | Intranasal naloxone compositions and methods of making and using same |
ES2631504B1 (es) * | 2014-03-14 | 2018-11-28 | Opiant Pharmaceuticals, Inc. | Medicamentos de administración nasal y métodos para su uso |
JP6945614B2 (ja) * | 2014-03-26 | 2021-10-06 | オプティノーズ アズ | 経鼻投与 |
SG11201610685XA (en) * | 2014-06-25 | 2017-01-27 | Optinose As | Nasal administration |
WO2016099274A1 (en) | 2014-12-19 | 2016-06-23 | Avantium Knowledge Centre B.V. | Improved process for the preparation of a benzene compound |
CN104474534A (zh) * | 2014-12-22 | 2015-04-01 | 哈德逊(天津)生物技术有限责任公司 | 白介素-18抗病毒口腔喷剂 |
JP2016153391A (ja) * | 2015-02-16 | 2016-08-25 | 日本合成化学工業株式会社 | 無水酢酸ナトリウム結晶 |
EP3316865A4 (en) | 2015-07-02 | 2019-01-23 | Civitas Therapeutics, Inc. | POWDERS CONTAINING TRIPTAN, FOR PULMONARY DELIVERY |
CN109640947A (zh) * | 2016-08-05 | 2019-04-16 | 株式会社新日本科学 | 鼻内药物粉末组合物 |
US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
CN111712233A (zh) * | 2018-02-26 | 2020-09-25 | 株式会社新日本科学 | 粉末制剂、药筒及装置 |
WO2019182745A1 (en) | 2018-03-19 | 2019-09-26 | Bryn Pharma, LLC | Epinephrine spray formulations |
US10758532B2 (en) | 2018-12-11 | 2020-09-01 | Satsuma Pharmaceuticals, Inc. | Compositions, devices, and methods for treating or preventing headaches |
US11433063B1 (en) | 2019-03-12 | 2022-09-06 | Belhaven Biopharma, Inc. | Intranasal composition of pharmaceutical countermeasures for chemical warfare nerve agents and accidental exposure to organophosphate pesticides |
US20220183971A1 (en) * | 2019-05-16 | 2022-06-16 | Shin Nippon Biomedical Laboratories, Ltd. | Powder formulation for intranasal administration, and manufacturing method thereof |
US11400045B2 (en) * | 2020-03-16 | 2022-08-02 | Nasus Pharma Ltd. | Treatment with powdered intranasal epinephrine |
WO2022132018A1 (en) * | 2020-12-16 | 2022-06-23 | Liw Innovation Ab | A new powder composition |
US11617716B2 (en) | 2021-06-10 | 2023-04-04 | Belhaven BioPharma Inc. | Dry powder formulations of epinephrine and associated methods |
Family Cites Families (131)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2224175B1 (ja) | 1973-04-04 | 1978-04-14 | Isf Spa | |
IT1017153B (it) | 1974-07-15 | 1977-07-20 | Isf Spa | Apparecchio per inalazioni |
JPS53127553A (en) | 1977-04-13 | 1978-11-07 | Asahi Chem Ind Co Ltd | Vehicle |
JPS5420126A (en) | 1977-07-12 | 1979-02-15 | Asahi Chem Ind Co Ltd | Pharmaceutical composition |
AU508480B2 (en) | 1977-04-13 | 1980-03-20 | Asahi Kasei Kogyo Kabushiki Kaisha | Microcrystalline cellulose excipient and pharmaceutical composition containing thesame |
JPS5462328A (en) | 1977-10-24 | 1979-05-19 | Asahi Chem Ind Co Ltd | Additive for cosmetics |
US4226233A (en) | 1978-10-10 | 1980-10-07 | Longevity Products, Inc. | Respirators |
US4300545A (en) | 1980-06-23 | 1981-11-17 | Schering Corporation | Method and nozzle for nasal vaccination of immature mammals |
JPS5934267A (ja) | 1982-08-23 | 1984-02-24 | 帝人株式会社 | 粉状薬剤施薬装置 |
JPS59163313A (ja) | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
DE3345722A1 (de) | 1983-12-17 | 1985-06-27 | Boehringer Ingelheim KG, 6507 Ingelheim | Inhalator |
JPS60224616A (ja) | 1984-04-24 | 1985-11-09 | Teijin Ltd | 経鼻投与用組成物 |
JPS6242888A (ja) | 1985-08-21 | 1987-02-24 | カシオ計算機株式会社 | 太陽電池を備えたicカ−ド |
US5731303A (en) | 1985-12-04 | 1998-03-24 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery compositions |
JPS63267731A (ja) | 1987-04-23 | 1988-11-04 | Asahi Chem Ind Co Ltd | 錠剤組成物 |
JP2851627B2 (ja) | 1987-10-15 | 1999-01-27 | シンテックス(ユー・エス・エイ)インコーポレイテッド | 粉末形態ポリプペチド類の経鼻投与 |
JPH02196719A (ja) | 1989-01-24 | 1990-08-03 | Green Cross Corp:The | 粉末状医薬組成物 |
US4947097A (en) | 1989-06-12 | 1990-08-07 | The Grass Valley Group, Inc. | Automatic switching of motion control with tactile feedback |
JP2726177B2 (ja) | 1991-08-01 | 1998-03-11 | 帝人株式会社 | 安定化されたカルシトニン類医薬組成物 |
DK198591D0 (da) | 1991-12-10 | 1991-12-10 | Novo Nordisk As | Apparat |
US5320094A (en) | 1992-01-10 | 1994-06-14 | The Johns Hopkins University | Method of administering insulin |
US5647345A (en) * | 1992-05-12 | 1997-07-15 | Saul; Gilbert D. | Respiratory stimulator & methods of use |
GB2269992A (en) | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
US5417984A (en) | 1992-12-14 | 1995-05-23 | Biocontrol, Inc. | Low crystallinity cellulose excipients |
US5672581A (en) | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
JPH08509465A (ja) | 1993-01-29 | 1996-10-08 | マイリス メディカル コーポレーション | ホルモンの肺内送達 |
US5756483A (en) | 1993-03-26 | 1998-05-26 | Merkus; Franciscus W. H. M. | Pharmaceutical compositions for intranasal administration of apomorphine |
JPH07165613A (ja) * | 1993-10-19 | 1995-06-27 | Dot:Kk | 経鼻吸収薬物用キャリヤおよび生理活性ペプチド組成物 |
SE9303574D0 (sv) | 1993-11-01 | 1993-11-01 | Kabi Pharmacia Ab | Composition for drug delivery and method the manufacturing thereof |
JP3414539B2 (ja) | 1994-05-11 | 2003-06-09 | 有限会社ドット | 経鼻吸収用組成物 |
US5958458A (en) * | 1994-06-15 | 1999-09-28 | Dumex-Alpharma A/S | Pharmaceutical multiple unit particulate formulation in the form of coated cores |
JPH09503023A (ja) | 1994-06-16 | 1997-03-25 | フアルマシア・エツセ・ピー・アー | 生物付着性澱粉及び該澱粉の製造方法 |
JPH0898888A (ja) | 1994-09-30 | 1996-04-16 | Teijin Ltd | 粉末状薬剤噴霧施薬装置 |
JP3308419B2 (ja) | 1995-02-06 | 2002-07-29 | 株式会社ユニシアジェックス | 鼻腔用投薬器 |
JP3308425B2 (ja) | 1995-03-10 | 2002-07-29 | 株式会社ユニシアジェックス | 鼻腔用投薬器 |
JPH08243164A (ja) | 1995-03-13 | 1996-09-24 | Unisia Jecs Corp | 鼻腔用投薬器 |
JP3320261B2 (ja) | 1995-06-01 | 2002-09-03 | 株式会社ユニシアジェックス | 吸入式投薬器 |
JP3098401B2 (ja) | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
JP3317827B2 (ja) | 1995-10-09 | 2002-08-26 | 株式会社ユニシアジェックス | 投薬器 |
JP3197221B2 (ja) * | 1996-02-27 | 2001-08-13 | 帝人株式会社 | 吸収性が改善された粉末状経鼻投与組成物 |
JP3634380B2 (ja) | 1996-02-27 | 2005-03-30 | 帝人株式会社 | 粉末状経鼻投与組成物 |
JP3197223B2 (ja) | 1996-02-28 | 2001-08-13 | 帝人株式会社 | 即効性と持続性を兼ね備えた粉末状経鼻投与用組成物 |
JPH09253208A (ja) | 1996-03-21 | 1997-09-30 | Unisia Jecs Corp | 鼻腔用投薬器 |
JPH09276405A (ja) | 1996-04-15 | 1997-10-28 | Unisia Jecs Corp | 鼻腔用投薬器 |
US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
JP3020141B2 (ja) | 1996-10-07 | 2000-03-15 | 株式会社富士薬品 | 経鼻投与用製剤 |
GB9700624D0 (en) * | 1997-01-14 | 1997-03-05 | Danbiosyst Uk | Drug delivery composition |
WO1998033540A1 (fr) | 1997-01-30 | 1998-08-06 | Unisia Jecs Corporation | Applicateur de medicament du type a aspiration |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
EP1019023B1 (en) * | 1997-09-29 | 2003-05-07 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in nebulizers |
RU2184570C2 (ru) | 1997-09-30 | 2002-07-10 | Дайити Фармасьютикал Ко., Лтд. | Препараты для орального введения |
FR2771012B1 (fr) | 1997-11-17 | 2000-03-10 | Sofab | Pulverisateur nasal |
JPH11216357A (ja) | 1998-02-03 | 1999-08-10 | Tsutsumi Techno Planning Kk | 生理活性物質用の吸着担体 |
JP3530004B2 (ja) | 1998-02-06 | 2004-05-24 | 株式会社日立ユニシアオートモティブ | 吸入式投薬器 |
GB9807232D0 (en) | 1998-04-03 | 1998-06-03 | Univ Cardiff | Aerosol composition |
JPH11322582A (ja) * | 1998-05-06 | 1999-11-24 | Dot:Kk | 経鼻吸収用鼻粘膜付着・滞留型キャリヤ |
GT199900061A (es) | 1998-05-15 | 2000-10-14 | Pfizer | Formulaciones farmaceuticas. |
PL344586A1 (en) * | 1998-06-05 | 2001-11-05 | Warner Lambert Co | Stabilization of compositions containing ace inhibitors using magnesium oxide |
TWI223598B (en) | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
DK1025859T3 (da) * | 1998-08-26 | 2006-10-16 | Teijin Ltd | Pulverformige pernasale præparater |
CA2341732C (en) | 1998-08-26 | 2008-08-19 | Teijin Limited | Powder composition for nasal administration |
ATE347880T1 (de) | 1998-10-20 | 2007-01-15 | Univ North Carolina | Methoden zum befeuchten der nasenschleimhaut |
GB9828721D0 (en) | 1998-12-24 | 1999-02-17 | Glaxo Group Ltd | Novel apparatus and process |
JP2000229859A (ja) | 1999-02-12 | 2000-08-22 | Teijin Ltd | 安定なブプレノルフィン経鼻製剤 |
JP2000239187A (ja) | 1999-02-22 | 2000-09-05 | Dotto:Kk | 経鼻吸収用組成物 |
US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
JP3912469B2 (ja) | 1999-05-13 | 2007-05-09 | セイコーエプソン株式会社 | 偽造印刷物判定用インク |
JP2001055323A (ja) * | 1999-08-12 | 2001-02-27 | Teijin Ltd | 粉末状経鼻投与用組成物 |
US6197328B1 (en) | 1999-08-20 | 2001-03-06 | Dott Research Laboratory | Nasally administrable compositions |
EP1238661A1 (en) * | 1999-10-12 | 2002-09-11 | Kaken Pharmaceutical Co., Ltd. | Powdery inhalational preparations and process for producing the same |
DE10049392A1 (de) | 1999-10-14 | 2001-04-19 | Becton Dickinson Co | Flüssigkeits-Ausgabevorrichtung |
GB9925934D0 (en) | 1999-11-03 | 1999-12-29 | Glaxo Group Ltd | Novel apparatus and process |
CA2396381A1 (en) * | 2000-01-20 | 2001-07-26 | Akira Yanagawa | Nasally administrable cyclic peptide compositions |
DK1291031T3 (da) | 2000-06-12 | 2006-10-09 | Teijin Ltd | Multidosis-administrationsindretning til pulverformig medicin |
DE10031043A1 (de) | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
US7709461B2 (en) | 2000-10-18 | 2010-05-04 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
US6595210B2 (en) | 2000-11-27 | 2003-07-22 | Unisia Jecs Corporation | Inhalator for administering powder composition |
JP2002255795A (ja) | 2001-02-26 | 2002-09-11 | Teijin Ltd | 経鼻投与用組成物 |
WO2002094233A1 (en) | 2001-05-24 | 2002-11-28 | Alexza Molecular Delivery Corporation | Delivery of antiemetics through an inhalation route |
CN100341567C (zh) * | 2001-07-05 | 2007-10-10 | 产业化研究株式会社 | 胰岛素的经鼻给药用组合物 |
AU2002333644A1 (en) | 2001-09-17 | 2003-04-01 | Glaxo Group Limited | Dry powder medicament formulations |
PT1443912E (pt) | 2001-10-12 | 2007-11-28 | Elan Pharma Int Ltd | Composições tendo uma combinação de características de libertação imediata e de libertação controlada |
JP3975327B2 (ja) | 2001-11-19 | 2007-09-12 | 株式会社 バイオアクティス | 鼻腔用粉状薬剤施薬装置 |
US20040092428A1 (en) | 2001-11-27 | 2004-05-13 | Hongming Chen | Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof |
JP2003175103A (ja) | 2001-12-12 | 2003-06-24 | Teijin Ltd | 粉末薬剤多回投与器 |
FR2834212B1 (fr) * | 2001-12-27 | 2004-07-09 | Besins Int Belgique | Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques |
JP4212019B2 (ja) * | 2002-01-09 | 2009-01-21 | Translational Research 株式会社 | 薬物の経鼻投与用組成物 |
WO2003077825A2 (en) | 2002-03-12 | 2003-09-25 | Microdose Technologies, Inc. | Site specific delivery of co-administered drugs via inhalation |
AU2003209851A1 (en) | 2002-03-20 | 2003-09-29 | The University Of Queensland | Method of treatment and/or prophylaxis |
JP3950738B2 (ja) | 2002-05-14 | 2007-08-01 | 株式会社 バイオアクティス | 鼻腔用粉状薬剤施薬装置 |
AU2003280102B2 (en) | 2002-06-28 | 2007-01-25 | Alkermes, Inc. | Inhalable epinephrine |
WO2004004692A1 (en) | 2002-07-08 | 2004-01-15 | Ranbaxy Laboratories Limited | Processes for the preparation of oral dosage formulations of modafinil |
GB0215904D0 (en) | 2002-07-09 | 2002-08-21 | Team Holdings Uk Ltd | Drug delivery system and method |
US6855913B2 (en) | 2002-08-06 | 2005-02-15 | Hobart Brothers Company | Flux-cored wire formulation for welding |
GB2395900A (en) | 2002-12-04 | 2004-06-09 | Elan Drug Delivery Ltd | Therapeutic composition for respiratory delivery |
GB0228826D0 (en) * | 2002-12-11 | 2003-01-15 | Okpala Joseph | Hair technology in creating particles with improved delivery capabilities |
US20040173211A1 (en) | 2003-01-14 | 2004-09-09 | Boehringer Ingelheim International Gmbh | Powder inhaler |
CN100581586C (zh) | 2003-01-31 | 2010-01-20 | 奥雷克索公司 | 一种快速起效的药物组合物 |
US7638138B2 (en) * | 2003-02-21 | 2009-12-29 | Translational Research, Ltd. | Compositions for nasal administration of pharmaceuticals |
JP4136724B2 (ja) | 2003-03-05 | 2008-08-20 | 株式会社日立製作所 | 鼻腔用投薬器 |
US20060116657A1 (en) | 2003-03-21 | 2006-06-01 | Daniel Schmid | Mixing capsule |
AU2003220808B2 (en) | 2003-03-27 | 2008-08-21 | Bioactis Limited | Powder medicine applicator for nasal cavity |
AU2004247076A1 (en) | 2003-06-06 | 2004-12-23 | Glaxo Group Limited | Composition comprising triptans and NSAIDs |
WO2004112702A2 (en) | 2003-06-13 | 2004-12-29 | Advanced Inhalation Research, Inc. | Low dose pharmaceutical powders for inhalation |
US20050042177A1 (en) | 2003-07-23 | 2005-02-24 | Elan Pharma International Ltd. | Novel compositions of sildenafil free base |
US7722566B2 (en) | 2003-10-09 | 2010-05-25 | Shin Nippon Biomedical Laboratories, Ltd. | Device to deliver a powdery medicine into nasal cavity |
GB0328186D0 (en) | 2003-12-05 | 2004-01-07 | West Pharm Serv Drug Res Ltd | Intranasal compositions |
US8545881B2 (en) | 2004-04-19 | 2013-10-01 | Eurand Pharmaceuticals, Ltd. | Orally disintegrating tablets and methods of manufacture |
RU2006141358A (ru) * | 2004-04-23 | 2008-05-27 | Сайдекс, Инк. (Us) | Препаративная форма для ингалятора сухого порошка, содержащая простой сульфоалкиловый эфир циклодекстрина |
JP4922762B2 (ja) | 2004-08-10 | 2012-04-25 | 株式会社新日本科学 | 速効性でかつ高い吸収性を可能とする経鼻投与用組成物 |
US9283335B2 (en) | 2004-10-06 | 2016-03-15 | Boehringer Ingelheim International Gmbh | Dispensing device, storage device and method for dispensing powder |
BRPI0515932A (pt) | 2004-10-15 | 2008-08-12 | Pfizer Prod Inc | composições e métodos para distribuição intranasal, bucal, sublingual e pulmonar de vareniclina |
GB0425758D0 (en) * | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
US7036787B1 (en) * | 2005-02-04 | 2006-05-02 | Taiwan Thick-Film Ind. Corp. | Display strut adjusting structure |
CA2617909C (en) * | 2005-08-05 | 2014-02-04 | 3M Innovative Properties Company | Compositions exhibiting improved flowability |
US8998881B2 (en) | 2005-08-10 | 2015-04-07 | Alza Corporation | Method for delivering drugs to tissue under microjet propulsion |
US20070098804A1 (en) | 2005-08-29 | 2007-05-03 | Judith Aronhime | Solid particulate tadalafil having a bimodal particle size distribution |
US8106100B2 (en) * | 2005-12-06 | 2012-01-31 | Asahi Kasei Chemicals Corporation | Process for producing tablet by high-speed direct compression |
US20070178164A1 (en) | 2006-01-31 | 2007-08-02 | Sigal Blau | Pharmaceutical formulations of oxcarbazepine and methods for its preparation |
TW200811104A (en) | 2006-04-25 | 2008-03-01 | Theravance Inc | Crystalline forms of a dimethylphenyl compound |
US7806117B2 (en) | 2006-06-07 | 2010-10-05 | Shin Nippon Biomedical Laboratories, Ltd. | Peroral powder delivery device |
CA2659245A1 (en) | 2006-07-28 | 2008-01-31 | Novadel Pharma Inc. | Anti-migraine oral spray formulations and methods |
US20080029084A1 (en) | 2006-08-04 | 2008-02-07 | Nastech Pharmaceutical Company Inc. | Device for improved peptide delivery |
US8058278B2 (en) | 2006-09-07 | 2011-11-15 | Parion Sciences, Inc. | Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
GB0625322D0 (en) | 2006-12-19 | 2007-01-24 | Pharmakodex Ltd | Pharmaceutical compositions |
ES2652415T3 (es) | 2006-12-26 | 2018-02-02 | Shin Nippon Biomedical Laboratories, Ltd. | Preparación para aplicación transnasal |
GB2448183A (en) | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device |
US8486043B2 (en) | 2007-10-12 | 2013-07-16 | Map Pharmaceuticals, Inc. | Inhalation drug delivery |
US20110077272A1 (en) | 2008-02-01 | 2011-03-31 | Vectura Limited | Pulmonary formulations of triptans |
JP2012526726A (ja) | 2009-05-15 | 2012-11-01 | 株式会社新日本科学 | 薬物動態が改善された鼻腔内用薬学的組成物 |
WO2011013003A2 (en) | 2009-07-31 | 2011-02-03 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
-
2007
- 2007-12-25 ES ES07860016.0T patent/ES2652415T3/es active Active
- 2007-12-25 WO PCT/JP2007/074787 patent/WO2008078730A1/ja active Application Filing
- 2007-12-25 JP JP2008551108A patent/JP5415769B2/ja active Active
- 2007-12-25 CN CN2007800510411A patent/CN101668544B/zh active Active
- 2007-12-25 EP EP07860016.0A patent/EP2116264B1/en active Active
- 2007-12-25 US US12/521,116 patent/US8337817B2/en active Active
-
2010
- 2010-09-10 HK HK10108585.2A patent/HK1142001A1/xx unknown
-
2012
- 2012-10-11 US US13/649,515 patent/US10195139B2/en active Active
-
2013
- 2013-10-07 JP JP2013209951A patent/JP2014028848A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2116264B1 (en) | 2017-09-27 |
EP2116264A4 (en) | 2012-01-18 |
ES2652415T3 (es) | 2018-02-02 |
US8337817B2 (en) | 2012-12-25 |
WO2008078730A1 (ja) | 2008-07-03 |
EP2116264A1 (en) | 2009-11-11 |
US20100178331A1 (en) | 2010-07-15 |
JPWO2008078730A1 (ja) | 2010-04-30 |
JP5415769B2 (ja) | 2014-02-12 |
CN101668544B (zh) | 2013-04-24 |
US20130095145A1 (en) | 2013-04-18 |
US10195139B2 (en) | 2019-02-05 |
CN101668544A (zh) | 2010-03-10 |
US20150017212A9 (en) | 2015-01-15 |
JP2014028848A (ja) | 2014-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1142001A1 (en) | Preparation for transnasal application | |
GB0602424D0 (en) | Compounds | |
GB0602046D0 (en) | Compounds | |
GB0605786D0 (en) | Compounds | |
EP2116535A4 (en) | GLUCKINASE ACTIVATING SUBSTANCE | |
EP1984379A4 (en) | ANTI-ARENAVIRAL COMPOUNDS | |
IL195074A0 (en) | Imidazoazepinone compounds | |
GB0605784D0 (en) | Compounds | |
GB0605785D0 (en) | Compounds | |
EP2082022A4 (en) | COMPOUNDS | |
EP2004174A4 (en) | NAPHTHALENEDIONED COMPOUNDS | |
EP1973905A4 (en) | COMPOUNDS | |
AP2009004767A0 (en) | Cubstituted azolin-2-yl-amino compounds | |
EP2016069A4 (en) | BISPYRIDINIUMVERBINDUNGEN | |
GB0602560D0 (en) | Compounds | |
GB0602412D0 (en) | Compounds | |
GB0600427D0 (en) | Compounds | |
HU0600193V0 (en) | Latch-cover for water-network | |
PL380476A1 (pl) | Preparat farmaceutyczny | |
GB0609547D0 (en) | My Gogglebox | |
GB0602134D0 (en) | Compounds | |
GB0602559D0 (en) | Compounds | |
GB0602853D0 (en) | Compounds | |
GB0602856D0 (en) | Compounds | |
GB0602558D0 (en) | Compounds |